Statistics for Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma : KEYNOTE-240
Total visits
| views | |
|---|---|
| Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma : KEYNOTE-240 | 52 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| Health-related quality-of-life impact of pembrolizumab versus best supportive care.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 40 |
| Chile | 7 |
| Germany | 2 |
| Switzerland | 1 |
| Israel | 1 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 36 |
| Santiago | 7 |
| Alameda | 2 |
| Balingen | 1 |
| Campbell | 1 |
| Sacramento | 1 |
| Tel Aviv | 1 |
| Zapopan | 1 |
| Zurich | 1 |